why choose us

Clinical Trials Search

Showing 5,800 of 132,085 result(s)
Effect of tDCS Along With Relaxation Technique on Anxiety Level in Students Preparing for Competitive Exams

Status: Completed

Condition: Anxiety

Interventions: tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.

Date: 2023-12-11

EFFECT OF SACRAL ERECTOR SPINA PLAN BLOCK ON TOTAL HIP ARTHROPLASTY

Status: COMPLETED

Condition: Postoperative Pain

Interventions: sacral erectör spinae plane will be applied to patients in Group S

Date: 2023-12-11

Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma

Status: Completed

Condition: Endometriosis Ovary

Interventions:

Date: 2023-12-11

Prediction of Acute Kidney Injury in Patients With Sepsis Using Venous Excess Ultrasound Score

Status: Completed

Condition: Intensive Care Unit

Interventions:

-- The IVC diameter : Grade 0: <5 mm with respiratory variation Grade I: 5-9 mm with respiratory variation Grade II: 10-19 mm with respiratory v

Date: 2023-12-11

Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney

Status: Completed

Condition: Prostate Cancer

Interventions:

Date: 2023-12-11

Promoting Recovery Outcomes Through Precise Early Locomotor Interventions in Persons With Spinal Cord Injury

Status: NOT_YET_RECRUITING

Condition: Spinal Cord Injuries

Interventions: For these training sessions, participants will undergo walking training sessions that consist of wearing a harness for either body weight support or a

Date: 2023-12-11

A Study of Oral Kavalactones Effect on Nurses

Status: NOT_YET_RECRUITING

Condition: Stress

Interventions: Three 75 mg capsules orally once daily within one hour of bedtime (225 mg total;day)

Date: 2023-12-11

Lerapolturev (PVSRIPO) in GBM

Status: NOT_YET_RECRUITING

Condition: Recurrent Supratentorial Glioblastoma

Interventions:

Lerapolturev (intratumoral) will be dosed at 2x108 TCID50 in 3.0 mL x 2 doses (total dose 4x108 TCID50) by Convection Enhanced Delivery.

For

Date: 2023-12-11

Increasing Screening for Cancer Using EHR-Nudges

Status: ENROLLING_BY_INVITATION

Condition: Breast Cancer

Interventions: Patients will be sent text message reminders 4 days and 14 days after their primary care visit.
The message delivered 4-days post-visit will remi

Date: 2023-12-11

SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)

Status: Completed

Condition: Retinal Dystrophies

Interventions: The investigational swept source OCT systems with handheld UC handpieces used in this study were developed at Duke University.
OCT systems are no

Date: 2023-12-11